Clinical practice guideline: sudden hearing loss
- PMID: 22383545
- DOI: 10.1177/0194599812436449
Clinical practice guideline: sudden hearing loss
Abstract
Objective: Sudden hearing loss (SHL) is a frightening symptom that often prompts an urgent or emergent visit to a physician. This guideline provides evidence-based recommendations for the diagnosis, management, and follow-up of patients who present with SHL. The guideline primarily focuses on sudden sensorineural hearing loss (SSNHL) in adult patients (aged 18 and older). Prompt recognition and management of SSNHL may improve hearing recovery and patient quality of life (QOL). Sudden sensorineural hearing loss affects 5 to 20 per 100,000 population, with about 4000 new cases per year in the United States. This guideline is intended for all clinicians who diagnose or manage adult patients who present with SHL.
Purpose: The purpose of this guideline is to provide clinicians with evidence-based recommendations in evaluating patients with SHL, with particular emphasis on managing SSNHL. The panel recognized that patients enter the health care system with SHL as a nonspecific, primary complaint. Therefore, the initial recommendations of the guideline deal with efficiently distinguishing SSNHL from other causes of SHL at the time of presentation. By focusing on opportunities for quality improvement, the guideline should improve diagnostic accuracy, facilitate prompt intervention, decrease variations in management, reduce unnecessary tests and imaging procedures, and improve hearing and rehabilitative outcomes for affected patients.
Results: The panel made strong recommendations that clinicians should (1) distinguish sensorineural hearing loss from conductive hearing loss in a patient presenting with SHL; (2) educate patients with idiopathic sudden sensorineural hearing loss (ISSNHL) about the natural history of the condition, the benefits and risks of medical interventions, and the limitations of existing evidence regarding efficacy; and (3) counsel patients with incomplete recovery of hearing about the possible benefits of amplification and hearing-assistive technology and other supportive measures. The panel made recommendations that clinicians should (1) assess patients with presumptive SSNHL for bilateral SHL, recurrent episodes of SHL, or focal neurologic findings; (2) diagnose presumptive ISSNHL if audiometry confirms a 30-dB hearing loss at 3 consecutive frequencies and an underlying condition cannot be identified by history and physical examination; (3) evaluate patients with ISSNHL for retrocochlear pathology by obtaining magnetic resonance imaging, auditory brainstem response, or audiometric follow-up; (4) offer intratympanic steroid perfusion when patients have incomplete recovery from ISSNHL after failure of initial management; and (5) obtain follow-up audiometric evaluation within 6 months of diagnosis for patients with ISSNHL. The panel offered as options that clinicians may offer (1) corticosteroids as initial therapy to patients with ISSNHL and (2) hyperbaric oxygen therapy within 3 months of diagnosis of ISSNHL. The panel made a recommendation against clinicians routinely prescribing antivirals, thrombolytics, vasodilators, vasoactive substances, or antioxidants to patients with ISSNHL. The panel made strong recommendations against clinicians (1) ordering computerized tomography of the head/brain in the initial evaluation of a patient with presumptive SSNHL and (2) obtaining routine laboratory tests in patients with ISSNHL.
Similar articles
-
Clinical Practice Guideline: Sudden Hearing Loss (Update).Otolaryngol Head Neck Surg. 2019 Aug;161(1_suppl):S1-S45. doi: 10.1177/0194599819859885. Otolaryngol Head Neck Surg. 2019. PMID: 31369359
-
Clinical Practice Guideline: Sudden Hearing Loss (Update) Executive Summary.Otolaryngol Head Neck Surg. 2019 Aug;161(2):195-210. doi: 10.1177/0194599819859883. Otolaryngol Head Neck Surg. 2019. PMID: 31369349
-
Clinical practice guideline: Otitis media with effusion.Otolaryngol Head Neck Surg. 2004 May;130(5 Suppl):S95-118. doi: 10.1016/j.otohns.2004.02.002. Otolaryngol Head Neck Surg. 2004. PMID: 15138413
-
Controversies in the management of sudden sensorineural hearing loss: an evidence-based review.Clin Otolaryngol. 2015 Jun;40(3):176-82. doi: 10.1111/coa.12363. Clin Otolaryngol. 2015. PMID: 25521864 Review.
-
Clinical practice guideline: benign paroxysmal positional vertigo.Otolaryngol Head Neck Surg. 2008 Nov;139(5 Suppl 4):S47-81. doi: 10.1016/j.otohns.2008.08.022. Otolaryngol Head Neck Surg. 2008. PMID: 18973840 Review.
Cited by
-
High Total Cholesterol in Peripheral Blood Correlates with Poorer Hearing Recovery in Idiopathic Sudden Sensorineural Hearing Loss.PLoS One. 2015 Jul 24;10(7):e0133300. doi: 10.1371/journal.pone.0133300. eCollection 2015. PLoS One. 2015. PMID: 26208311 Free PMC article.
-
Ménière's Disease: A CHEER Database Study of Local and Regional Patient Encounter and Procedure Patterns.Otolaryngol Head Neck Surg. 2016 Jul;155(1):15-21. doi: 10.1177/0194599815617752. Otolaryngol Head Neck Surg. 2016. PMID: 27371621 Free PMC article.
-
Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss: a meta-analysis.Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3699-3711. doi: 10.1007/s00405-016-4041-2. Epub 2016 Apr 12. Eur Arch Otorhinolaryngol. 2016. PMID: 27071771
-
Hearing Changes After Intratympanically Applied Steroids for Primary Therapy of Sudden Hearing Loss: A Meta-analysis Using Mathematical Simulations of Drug Delivery Protocols.Otol Neurotol. 2017 Jan;38(1):19-30. doi: 10.1097/MAO.0000000000001254. Otol Neurotol. 2017. PMID: 27779563 Free PMC article.
-
Clinical impact of hyperbaric oxygen therapy combined with steroid treatment for sudden sensorineural hearing loss: A case-control study.Laryngoscope Investig Otolaryngol. 2024 Jul 3;9(4):e1297. doi: 10.1002/lio2.1297. eCollection 2024 Aug. Laryngoscope Investig Otolaryngol. 2024. PMID: 38974601 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous